<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>Proteome Science - Latest articles</title>
		<link>http://www.proteomesci.com</link>
		<description>The latest articles from Proteome Science (ISSN 1477-5956) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.proteomesci.com/content/6/1/19"/>			    
            
				    <rdf:li rdf:resource="http://www.proteomesci.com/content/6/1/18"/>			    
            
				    <rdf:li rdf:resource="http://www.proteomesci.com/content/6/1/17"/>			    
            
				    <rdf:li rdf:resource="http://www.proteomesci.com/content/6/1/16"/>			    
            
				    <rdf:li rdf:resource="http://www.proteomesci.com/content/6/1/15"/>			    
            
				    <rdf:li rdf:resource="http://www.proteomesci.com/content/6/1/14"/>			    
            
				    <rdf:li rdf:resource="http://www.proteomesci.com/content/6/1/13"/>			    
            
				    <rdf:li rdf:resource="http://www.proteomesci.com/content/6/1/12"/>			    
            
				    <rdf:li rdf:resource="http://www.proteomesci.com/content/6/1/11"/>			    
            
				    <rdf:li rdf:resource="http://www.proteomesci.com/content/6/1/10"/>			    
            
            </rdf:Seq>
        </items>
    </channel>  
    
		<item rdf:about="http://www.proteomesci.com/content/6/1/19">
            
            <title>Proteomic profiling of urine for the detection of colon cancer</title>
			<description>Background:
Colorectal cancer is the second most common cause of cancer related death in the developed world. To date, no blood or stool biomarkers with both high sensitivity and specificity for potentially curable early stage disease have been validated for clinical use. SELDI and MALDI profiling are being used increasingly to search for biomarkers in both blood and urine. Both techniques provide information predominantly on the low molecular weight proteome (&lt;15 kDa). There have been several reports that colorectal cancer is associated with changes in the serum proteome that are detectable by SELDI and we hypothesised that proteomic changes would also be detectable in urine.
Results:
We collected urine from 67 patients with colorectal cancer and 72 non-cancer control subjects, diluted to a constant protein concentration and generated MALDI and SELDI spectra. The intensities of 19 peaks differed significantly between cancer and non-cancer patients by both t-tests and after adjusting for confounders using multiple linear regressions. Logistic regression classifiers based on peak intensities identified colorectal cancer with up to 78% sensitivity at 87% specificity. We identified and independently quantified 3 of the discriminatory peaks using synthetic stable isotope peptides (an 1885 Da fragment of fibrinogen and hepcidin-20) or ELISA (&#946;2-microglobulin).
Conclusion:
Changes in the urine proteome may aid in the early detection of colorectal cancer.</description>
			<link>http://www.proteomesci.com/content/6/1/19</link>
			
			 	<dc:creator>Douglas G Ward, Stephen Nyangoma, Howard Joy, Emma Hamilton, Wenbin Wei, Chris Tselepis, Neil Steven, Michael JO Wakelam, Philip J Johnson, Tariq Ismail and Ashley Martin</dc:creator>
			
			<dc:source>Proteome Science 2008, 6:19</dc:source>
			<dc:date>2008-06-16</dc:date>
			<dc:identifier>doi:10.1186/1477-5956-6-19</dc:identifier>
			
			
							
					<prism:publicationName>Proteome Science</prism:publicationName>
					
			
							
					<prism:issn>1477-5956</prism:issn>
					
			
							
					<prism:volume>6</prism:volume>
					
			
							
					<prism:startingPage>19</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-16</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.proteomesci.com/content/6/1/18">
            
            <title>Identification of differentially expressed proteins in spontaneous thymic lymphomas from knockout mice with deletion of p53</title>
			<description>Background:
Knockout mice with a deletion of p53 spontaneously develop thymic lymphomas. Two cell lines (SM5 and SM7), established from two independent tumours, exhibited about fifty to seventy two-fold differentially expressed proteins compared to wild type thymocytes by two-dimensional gel electrophoresis (2D-PAGE).
Results:
Protein spots excised from 2D-PAGE gels, were subjected to in-gel tryptic digestion and identified by liquid chromatography - tandem mass spectrometry. A total of 47 protein spots were identified. Immunological verification was performed for several of the differentially regulated proteins where suitable antibodies could be obtained. Functional annotation clustering revealed similarities as well as differences between the tumours.Twelve proteins that changed similarly in both tumours included up-regulation of rho GDP-dissociation inhibitor 2, proteasome subunit alpha type 3, transforming acidic coiled-coil containing protein 3, mitochondrial ornithine aminotransferase and epidermal fatty acid binding protein and down-regulation of adenylosuccinate synthetase, tubulin beta-3 chain, a 25 kDa actin fragment, proteasome subunit beta type 9, cofilin-1 and glia maturation factor gamma.
Conclusions:
Some of the commonly differentially expressed proteins are also differentially expressed in other tumours and may be putative diagnostic and/or prognostic markers for lymphomas.</description>
			<link>http://www.proteomesci.com/content/6/1/18</link>
			
			 	<dc:creator>Bent Honore, Soren Buus and Mogens H Claesson</dc:creator>
			
			<dc:source>Proteome Science 2008, 6:18</dc:source>
			<dc:date>2008-06-10</dc:date>
			<dc:identifier>doi:10.1186/1477-5956-6-18</dc:identifier>
			
			
							
					<prism:publicationName>Proteome Science</prism:publicationName>
					
			
							
					<prism:issn>1477-5956</prism:issn>
					
			
							
					<prism:volume>6</prism:volume>
					
			
							
					<prism:startingPage>18</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-10</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.proteomesci.com/content/6/1/17">
            
            <title>Protein profiling of the dimorphic, pathogenic fungus, Penicillium marneffei</title>
			<description>Background:
Penicillium marneffei is a pathogenic fungus that afflicts immunocompromised individuals having lived or traveled in Southeast Asia.  This species is unique in that it is the only dimorphic member of the genus.  Dimorphism results from a process, termed phase transition, which is regulated by temperature of incubation.  At room temperature, the fungus grows filamentously (mould phase), but at body temperature (37degreesC), a uninucleate yeast form develops that reproduces by fission.  Formation of the yeast phase appears to be a requisite for pathogenicity. To date, no genes have been identified in P. marneffei that strictly induce mould-to-yeast phase conversion.  In an effort to help identify potential gene products associated with morphogenesis, protein profiles were generated from the yeast and mould phases of P. marneffei.
Results:
Whole cell proteins from the early stages of mould and yeast development in P. marneffei were resolved by two-dimensional gel electrophoresis.  Selected proteins were recovered and sequenced by capillary-liquid chromatography-nanospray tandem mass spectrometry. Putative identifications were derived by searching available databases for homologous fungal sequences.  Proteins found common to both mould and yeast phases included the signal transduction proteins cyclophilin and a RACK1-like ortholog, as well as those related to general metabolism, energy production, and protection from oxygen radicals.  Many of the mould-specific proteins identified possessed similar functions.  By comparison, proteins exhibiting increased expression during development of the parasitic yeast phase comprised those involved in heat-shock responses, general metabolism, and cell-wall biosynthesis, as well as a small GTPase that regulates nuclear membrane transport and mitotic processes in fungi.  The cognate gene encoding the latter protein, designated RanA, was subsequently cloned and characterized.  The P. marneffei RanA protein sequence, which contained the signature motif of Ran-GTPases, exhibited 90% homology to homologous Aspergillus proteins.
Conclusions:
This study clearly demonstrates the utility of proteomic approaches to studying dimorphism in P. marneffei.  Moreover, this strategy complements and extends current genetic methodologies directed towards understanding the molecular mechanisms of phase transition.  Finally, the documented increased levels of RanA expression suggest that cellular development in this fungus involves additional signaling mechanisms than have been previously described in P. marneffei. </description>
			<link>http://www.proteomesci.com/content/6/1/17</link>
			
			 	<dc:creator>Julie M Chandler, Erin R Treece, Heather R Trenary, Jessica L Brenneman, Tressa J Flickner, Jonathan L Frommelt, Zaw M Oo, Megan M Patterson, William T Rundle, Olga V Valle, Thomas D Kim, Gary R Walker and Chester R Cooper</dc:creator>
			
			<dc:source>Proteome Science 2008, 6:17</dc:source>
			<dc:date>2008-06-04</dc:date>
			<dc:identifier>doi:10.1186/1477-5956-6-17</dc:identifier>
			
			
							
					<prism:publicationName>Proteome Science</prism:publicationName>
					
			
							
					<prism:issn>1477-5956</prism:issn>
					
			
							
					<prism:volume>6</prism:volume>
					
			
							
					<prism:startingPage>17</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-04</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.proteomesci.com/content/6/1/16">
            
            <title>Pooling serum samples may lead to loss of potential biomarkers in SELDI-ToF MS proteomic profiling</title>
			<description>Background:
High throughput proteomic technology offers promise for the detection of disease biomarkers and proteomic signature patterns but biomarker discovery studies can be limited by cost factors when large sample size numbers are required. Pooling sera or plasma samples from disease cases potentially offers a solution to cost implications by reducing the standard errors of mass to charge values. Surface enhanced laser desorption/ionization time of flight (SELDI-ToF) mass spectra obtained from individual and pooled sera from invasive aspergillosis cases and controls were compared.
Results:
Pooling resulted in 50% loss of peak clusters detected in individual samples. Overall, loss was greatest for low intensity clusters. Peak intensities and case:control intensity ratios, among clusters not lost, demonstrated good reproducibility.
Conclusion:
Pooling sera results in significant potential biomarker loss when using SELDI-ToF MS.</description>
			<link>http://www.proteomesci.com/content/6/1/16</link>
			
			 	<dc:creator>S Tariq Sadiq and Dan Agranoff</dc:creator>
			
			<dc:source>Proteome Science 2008, 6:16</dc:source>
			<dc:date>2008-06-01</dc:date>
			<dc:identifier>doi:10.1186/1477-5956-6-16</dc:identifier>
			
			
							
					<prism:publicationName>Proteome Science</prism:publicationName>
					
			
							
					<prism:issn>1477-5956</prism:issn>
					
			
							
					<prism:volume>6</prism:volume>
					
			
							
					<prism:startingPage>16</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-01</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.proteomesci.com/content/6/1/15">
            
            <title>Comprehensive analysis of the mouse renal cortex using two-dimensional HPLC &#8211; tandem mass spectrometry</title>
			<description>Background:
Proteomic methodologies increasingly have been applied to the kidney to map the renal cortical proteome and to identify global changes in renal proteins induced by diseases such as diabetes. While progress has been made in establishing a renal cortical proteome using 1-D or 2-DE and mass spectrometry, the number of proteins definitively identified by mass spectrometry has remained surprisingly small. Low coverage of the renal cortical proteome as well as our interest in diabetes-induced changes in proteins found in the renal cortex prompted us to perform an in-depth proteomic analysis of mouse renal cortical tissue.
Results:
We report a large scale analysis of mouse renal cortical proteome using SCX prefractionation strategy combined with HPLC &#8211; tandem mass spectrometry. High-confidence identification of ~2,000 proteins, including cytoplasmic, nuclear, plasma membrane, extracellular and unknown/unclassified proteins, was obtained by separating tryptic peptides of renal cortical proteins into 60 fractions by SCX prior to LC-MS/MS. The identified proteins represented the renal cortical proteome with no discernible bias due to protein physicochemical properties, subcellular distribution, biological processes, or molecular function. The highest ranked molecular functions were characteristic of tubular epithelium, and included binding, catalytic activity, transporter activity, structural molecule activity, and carrier activity. Comparison of this renal cortical proteome with published human urinary proteomes demonstrated enrichment of renal extracellular, plasma membrane, and lysosomal proteins in the urine, with a lack of intracellular proteins. Comparison of the most abundant proteins based on normalized spectral abundance factor (NSAF) in this dataset versus a published glomerular proteome indicated enrichment of mitochondrial proteins in the former and cytoskeletal proteins in the latter.
Conclusion:
A whole tissue extract of the mouse kidney cortex was analyzed by an unbiased proteomic approach, yielding a dataset of ~2,000 unique proteins identified with strict criteria to ensure a high level of confidence in protein identification. As a result of extracting all proteins from the renal cortex, we identified an exceptionally wide range of renal proteins in terms of pI, MW, hydrophobicity, abundance, and subcellular location. Many of these proteins, such as low-abundance proteins, membrane proteins and proteins with extreme values in pI or MW are traditionally under-represented in 2-DE-based proteomic analysis.</description>
			<link>http://www.proteomesci.com/content/6/1/15</link>
			
			 	<dc:creator>Yingxin Zhao, Larry Denner, Sigmund J Haidacher, Wanda S LeJeune and Ronald G Tilton</dc:creator>
			
			<dc:source>Proteome Science 2008, 6:15</dc:source>
			<dc:date>2008-05-23</dc:date>
			<dc:identifier>doi:10.1186/1477-5956-6-15</dc:identifier>
			
			
							
					<prism:publicationName>Proteome Science</prism:publicationName>
					
			
							
					<prism:issn>1477-5956</prism:issn>
					
			
							
					<prism:volume>6</prism:volume>
					
			
							
					<prism:startingPage>15</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-23</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.proteomesci.com/content/6/1/14">
            
            <title>Proteomic changes in rat hippocampus and adrenals following short-term sleep deprivation</title>
			<description>Background:
To identify the biochemical changes induced by sleep deprivation at a proteomic level, we compared the hippocampal proteome of rats either after 4 hours of sleep or sleep deprivation obtained by gentle handling. Because sleep deprivation might induce some stress, we also analyzed proteomic changes in rat adrenals in the same conditions. After sleep deprivation, proteins from both tissues were extracted and subjected to 2D-DIGE analysis followed by protein identification through mass spectrometry and database search.
Results:
In the hippocampus, 87 spots showed significant variation between sleep and sleep deprivation, with more proteins showing higher abundance in the latter case. Among the 12 identified proteins, inferred affected cellular functions include cell metabolism, energy pathways, transport and vesicle trafficking, cytoskeleton and protein processing. Although we did not observe classical, macroscopic effect of stress in sleep-deprived rats, 47 protein spots showed significant variation in adrenal tissue between sleep and sleep deprivation, with more proteins showing higher abundance following sleep. Among the 13 identified proteins, the most relevant cellular function that is affected was cell metabolism.
Conclusions:
At a proteomic level, short term sleep deprivation is characterized by a higher expression of some proteins in the hippocampus and a lower abundance of other proteins in the adrenals (compared to normal sleep control). Altogether, this could indicate a general activation of a number of cellular mechanisms involved in the maintenance of wakefulness and in increased energy expenditure during sleep deprivation. These findings are relevant to suggested functions of sleep like energy repletion and the restoration of molecular stocks or a more global homeostasis of synaptic processes.</description>
			<link>http://www.proteomesci.com/content/6/1/14</link>
			
			 	<dc:creator>Jean-Etienne Poirrier, Francois Guillonneau, Jenny Renaut, Kjell Sergeant, Andre Luxen, Pierre Maquet and Pierre Leprince</dc:creator>
			
			<dc:source>Proteome Science 2008, 6:14</dc:source>
			<dc:date>2008-05-22</dc:date>
			<dc:identifier>doi:10.1186/1477-5956-6-14</dc:identifier>
			
			
							
					<prism:publicationName>Proteome Science</prism:publicationName>
					
			
							
					<prism:issn>1477-5956</prism:issn>
					
			
							
					<prism:volume>6</prism:volume>
					
			
							
					<prism:startingPage>14</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-22</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.proteomesci.com/content/6/1/13">
            
            <title>Proteome of monocyte priming by lipopolysaccharide, including changes in interleukin-1beta and leukocyte elastase inhibitor</title>
			<description>Background:
Monocytes can be primed in vitro by lipopolysaccharide (LPS) for release of cytokines, for enhanced killing of cancer cells, and for enhanced release of microbicidal oxygen radicals like superoxide and peroxide. We investigated the proteins involved in regulating priming, using 2D gel proteomics.
Results:
Monocytes from 4 normal donors were cultured for 16 h in chemically defined medium in Teflon bags &#177; LPS and &#177; 4-(2-aminoethyl)-benzenesulfonyl fluoride (AEBSF), a serine protease inhibitor. LPS-primed monocytes released inflammatory cytokines, and produced increased amounts of superoxide. AEBSF blocked priming for enhanced superoxide, but did not affect cytokine release, showing that AEBSF was not toxic. After staining large-format 2D gels with Sypro ruby, we compared the monocyte proteome under the four conditions for each donor. We found 30 protein spots that differed significantly in response to LPS or AEBSF, and these proteins were identified by ion trap mass spectrometry.
Conclusion:
We identified 19 separate proteins that changed in response to LPS or AEBSF, including ATP synthase, coagulation factor XIII, ferritin, coronin, HN ribonuclear proteins, integrin alpha IIb, pyruvate kinase, ras suppressor protein, superoxide dismutase, transketolase, tropomyosin, vimentin, and others. Interestingly, in response to LPS, precursor proteins for interleukin-1&#946; appeared; and in response to AEBSF, there was an increase in elastase inhibitor. The increase in elastase inhibitor provides support for our hypothesis that priming requires an endogenous serine protease.</description>
			<link>http://www.proteomesci.com/content/6/1/13</link>
			
			 	<dc:creator>Michael J Pabst, Karen M Pabst, David B Handsman, Sarka Beranova-Giorgianni and Francesco Giorgianni</dc:creator>
			
			<dc:source>Proteome Science 2008, 6:13</dc:source>
			<dc:date>2008-05-20</dc:date>
			<dc:identifier>doi:10.1186/1477-5956-6-13</dc:identifier>
			
			
							
					<prism:publicationName>Proteome Science</prism:publicationName>
					
			
							
					<prism:issn>1477-5956</prism:issn>
					
			
							
					<prism:volume>6</prism:volume>
					
			
							
					<prism:startingPage>13</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-20</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.proteomesci.com/content/6/1/12">
            
            <title>Proteome alteration induced by hTERT transfection of human fibroblast cells</title>
			<description>Background:
Telomerase confers cellular immortality by elongating telomeres, thereby circumventing the Hayflick limit. Extended-life-span cells have been generated by transfection with the human telomerase reverse transcriptase (hTERT) gene. hTERT transfected cell lines may be of outstanding interest to monitor the effect of drugs targeting the telomerase activity. The incidence of hTERT gene transfection at the proteome level is a prerequisite to that purpose. The effect of the transfection has been studied on the proteome of human fibroblast (WI38). Cytosolic and nuclear fractions of WI38 cells, empty vector transfected WI38 (WI38-HPV) and hTERT WI38 cells were submitted to a 2D-DIGE (Two-Dimensional Differential In-Gel Electrophoresis) analysis. Only spots that had a similar abundance in WI38 and WI38-HPV, but were differentially expressed in WI38 hTERT were selected for MS identification. This method directly points to the proteins linked with the hTERT expression. Number of false positive differentially expressed proteins has been excluded by using control WI38-HPV cells. The proteome alteration induced by hTERT WI38 transfection should be taken into account in subsequent use of the cell line for anti-telomerase drugs evaluation.
Results:
2D-DIGE experiment shows that 57 spots out of 2246 are significantly differentially expressed in the cytosolic fraction due to hTERT transfection, and 38 were confidently identified. In the nuclear fraction, 44 spots out of 2172 were selected in the differential proteome analysis, and 14 were identified. The results show that, in addition to elongating telomeres, hTERT gene transfection has other physiological roles, among which an enhanced ER capacity and a potent cell protection against apoptosis.
Conclusion:
We show that the methodology reduces the complexity of the proteome analysis and highlights proteins implicated in other processes than telomere elongation. hTERT induced proteome changes suggest that telomerase expression enhances natural cell repair mechanisms and stress resistance probably required for long term resistance of immortalized cells. Thus, hTERT transfected cells can not be only consider as an immortal equivalent to parental cells but also as cells which are over-resistant to stresses. These findings are the prerequisite for any larger proteomics aiming to evaluate anti-telomerase drugs proteome alteration and thus therapeutics induced cell reactions.</description>
			<link>http://www.proteomesci.com/content/6/1/12</link>
			
			 	<dc:creator>Gabriel D Mazzucchelli, Val&#233;rie Gabelica, Nicolas Smargiasso, Maximilien Fl&#233;ron, Wilson Ashimwe, Fr&#233;d&#233;ric Rosu, Marie-Claire De Pauw-Gillet, Jean-Fran&#231;ois Riou and Edwin De Pauw</dc:creator>
			
			<dc:source>Proteome Science 2008, 6:12</dc:source>
			<dc:date>2008-04-17</dc:date>
			<dc:identifier>doi:10.1186/1477-5956-6-12</dc:identifier>
			
			
							
					<prism:publicationName>Proteome Science</prism:publicationName>
					
			
							
					<prism:issn>1477-5956</prism:issn>
					
			
							
					<prism:volume>6</prism:volume>
					
			
							
					<prism:startingPage>12</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-17</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.proteomesci.com/content/6/1/11">
            
            <title>Proteomic analysis of the EhV-86 virion</title>
			<description>Background:
Emiliania huxleyi virus 86 (EhV-86) is the type species of the genus Coccolithovirus within the family Phycodnaviridae. The fully sequenced 407,339 bp genome is predicted to encode 473 protein coding sequences (CDSs) and is the largest Phycodnaviridae sequenced to date. The majority of EhV-86 CDSs exhibit no similarity to proteins in the public databases.
Results:
Proteomic analysis by 1-DE and then LC-MS/MS determined that the virion of EhV-86 is composed of at least 28 proteins, 23 of which are predicted to be membrane proteins. Besides the major capsid protein, putative function can be assigned to 4 other components of the virion: two lectin proteins, a thioredoxin and a serine/threonine protein kinase.
Conclusion:
This study represents the first steps toward the identification of the protein components that make up the EhV-86 virion. Aside from the major capsid protein, whose function in the virion is well known and defined, the nature of the other proteins suggest roles involved with viral budding, caspase activation, signalling, anti-oxidation, virus adsorption and host range determination.</description>
			<link>http://www.proteomesci.com/content/6/1/11</link>
			
			 	<dc:creator>Michael J Allen, Julie A Howard, Kathryn S Lilley and William H Wilson</dc:creator>
			
			<dc:source>Proteome Science 2008, 6:11</dc:source>
			<dc:date>2008-03-17</dc:date>
			<dc:identifier>doi:10.1186/1477-5956-6-11</dc:identifier>
			
			
							
					<prism:publicationName>Proteome Science</prism:publicationName>
					
			
							
					<prism:issn>1477-5956</prism:issn>
					
			
							
					<prism:volume>6</prism:volume>
					
			
							
					<prism:startingPage>11</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-03-17</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.proteomesci.com/content/6/1/10">
            
            <title>Detection and identification of NAP-2 as a biomarker in hepatitis B-related hepatocellular carcinoma by proteomic approach</title>
			<description>Background:
A lack of sensitive and specific biomarkers is a major reason for the high rate of Primary hepatocellular carcinoma (HCC)-related mortality. The aim of this study was to investigate potential proteomic biomarkers specific for HCC.
Methods:
81 patients with hepatitis B-related HCC and 33 healthy controls were randomly divided into a training set (33 HCC, 33 controls) and a testing set (48 HCC, 33 controls). Serum proteomic profiles were measured using Surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy (SELDI-TOF-MS).) A classification tree was established by Biomarker Pattern Software (BPS). Candidate SELDI peaks were isolated by tricine-SDS-PAGE, identified by HPLC-MS/MS and validated by immunohistochemistry (IHC) in liver tissues.
Results:
A total of 6 proteomic peaks (3157.33 m/z, 4177.02 m/z, 4284.79 m/z, 4300.80 m/z, 7789.87 m/z, and 7984.14 m/z) were chosen by BPS to establish a classification tree with the highest discriminatory power in the training set. The sensitivity and specificity of this classification tree were 95.92%, and 100% respectively in the testing set. A candidate marker of about 7984 m/z was isolated and identified as neutrophil-activating peptide 2 (NAP-2). IHC staining showed that NAP-2 signals were positive in HCC tissues but negative in adjacent tissues.
Conclusion:
The NAP-2 may be a specific proteomic biomarker of hepatitis B-related HCC.</description>
			<link>http://www.proteomesci.com/content/6/1/10</link>
			
			 	<dc:creator>Min He, Jian Qin, Rihong Zhai, Xiao Wei, Qi Wang, Minhua Rong, Zhihua Jiang, Yuanjiao Huang and Zhiyong Zhang</dc:creator>
			
			<dc:source>Proteome Science 2008, 6:10</dc:source>
			<dc:date>2008-03-10</dc:date>
			<dc:identifier>doi:10.1186/1477-5956-6-10</dc:identifier>
			
			
							
					<prism:publicationName>Proteome Science</prism:publicationName>
					
			
							
					<prism:issn>1477-5956</prism:issn>
					
			
							
					<prism:volume>6</prism:volume>
					
			
							
					<prism:startingPage>10</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-03-10</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
    <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
